# Arthomed, LLC. – FDA Inspection, Jan 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/arthomed-llc/a2580771-7d7e-4d89-9aeb-ee0d658ac101
Source feed: FDA_Inspections

> FDA inspection 1195570 of Arthomed, LLC., January 25, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195570
- Company Name: Arthomed, LLC.
- Inspection Date: 2023-01-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1081409 - 2019-02-22
- FDA Inspection 971857 - 2016-04-26
- [FDA Inspection 872590 - 2014-04-01](https://www.keypedia.com/records/fda_inspections/arthomed-llc/8ea701da-70b0-40a4-8520-9521b528e0e3)
- FDA Inspection 590672 - 2009-06-19

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)

Company: https://www.keypedia.com/companies/arthomed-llc/02f5a519-565c-4ddc-baab-977fa16d9776

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d